In contrast, TAAR6, TAAR8, and TAAR9 were expressed in 12.7%, 11.3%, and 5.3% of tumor specimens, respectively (Figure 2), so their expression is comparable with DRD2, of which expression and activity are well established in melanoma [27,40]. Here, TAAR9 is linked to melanoma.